Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-01-12, Stock:PFE, The news for the past five days is as follows:
2021-01-05: NEWS1: Ambulances put on alert as Los Angeles hospitals swamped by COVID-19 patients.NEWS2: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS3: Pfizer Launches First Major Rebranding in Over 70 Years.NEWS4: Peruvian minister raises 'controversy' over Pfizer vaccine liability clause.NEWS5: Coronavirus update: WHO and FDA differ on changes to COVID-19 vaccine dosing.NEWS6: New COVID-19 strains 'are making a difference': Doctor.NEWS7: 'We are in a race against time, and we have to get more people vaccinated': Fmr. WH COVID-19 Task Force Member.NEWS8: UK scientists question COVID-19 vaccine dosing delay.NEWS9: FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply.NEWS10: EU In Talks To Buy Up To 300M More Coronavirus Vaccine Doses From Pfizer-BioNTech.NEWS11: ‘Shortcuts right now’ with COVID-19 could lead to ‘far worse problems’ in the future: Doctor.NEWS12: EU seeks up to 100 mln more doses of Pfizer vaccine in new deal - sources.NEWS13: Pfizer Drops the Big Blue Pill to Highlight Shift in Strategy.NEWS14: Dutch caught off guard by Pfizer approval, unable to start vaccinations until Weds says PM.NEWS15: Here's What Investors Need to Know About COVID Vaccines and Allergic Reactions.NEWS16: EXPLAINER-How safe is it to switch and space COVID-19 vaccine doses?.NEWS17: Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference.NEWS18: EU Seeks Up to 300 Million More Pfizer-BioNTech Doses.NEWS19: Arcturus (ARCT) to Begin Phase II COVID-19 Vaccine Study.NEWS20: Why Is Europe Paying a Lot Less Than the U.S. for COVID Vaccines?.NEWS21: 2 Undervalued Stocks for 2021.NEWS22: Pfizer's (PFE) BLA for Somatrogon Gets FDA's Acceptance.NEWS23: Why Is Everyone Talking About Arcturus Therapeutics Stock?.NEWS24: Meet the 2021 Dogs of the Dow.NEWS25: Messing Around With Vaccine Doses Is a Gamble.NEWS26: A COVID-19 shot for $150? Online scams surge as slow vaccine rollout frustrates.NEWS27: Belgium to get half the Pfizer vaccine doses it ordered for January.NEWS28: FDA Warns Against Tinkering With Pfizer, Moderna Vaccine Regimens After White House Advisor's Comments.NEWS29: "Premature" to change authorized COVID-19 vaccines dosing, schedules, FDA says.
2021-01-06: NEWS1: Pelosi: Electoral Vote Count to Continue Tonight.NEWS2: Who's On the Hook If Vaccines Go Wrong?.NEWS3: Doctor on COVID-19 vaccine rollout: 'There's been a lack of coordination at the federal level'.NEWS4: Trump Tells Protesters to ‘Go Home in Peace’.NEWS5: Moderna Stock Gains After European Agency Recommends Covid Vaccine.NEWS6: This Small Gene Therapy Stock Is Taking On Giants Regeneron, Roche.NEWS7: Did You Miss Out on the Chance for Big Gains from Arcturus Stock?.NEWS8: Canadian care home residents challenge delay of second COVID-19 vaccine shot.NEWS9: Long-Term Treasury Yields Are Climbing as Investors Bet on Democratic Senate Wins.NEWS10: U.S. officials report more severe allergic reactions to COVID-19 vaccines.NEWS11: 5 reasons musicians like Bob Dylan, Neil Young and Stevie Nicks are selling their song catalogs right now.NEWS12: UK variant of COVID-19 could become the ‘dominant virus in the U.S.’ in the next few months: Doctor.NEWS13: EXPLAINER-How safe is it to switch and space COVID-19 vaccine doses?.NEWS14: FDA Opposes Dilution of COVID-19 Vaccine Doses: Here's Why.NEWS15: Slow vaccine rollout stokes tensions among EU states.NEWS16: Novavax Has Covid-19 Vaccine News Coming Out Soon. That Could Be Good for the Stock..NEWS17: Are States Prioritizing COVID Vaccinations Differently From CDC Guidelines?.NEWS18: Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy.NEWS19: WRAPUP 3-Moderna COVID-19 vaccine gets the green light in Europe.NEWS20: Is Pfizer Stock a Buy?.NEWS21: Nurse first in Netherlands to get COVID-19 vaccination.NEWS22: What Britain Can Learn From Israel About Vaccinations.NEWS23: Pizza-sized boxes and paying a premium: Israel's COVID-19 vaccine rollout.NEWS24: Europe Is Botching the Vaccine Rollout.NEWS25: Colombia regulator approves Pfizer-BioNTech vaccine for emergency use.
2021-01-07: NEWS1: Sarepta Crashes On Mixed Results For Gene Therapy In Muscular Dystrophy.NEWS2: This Covid Vaccine Stock Just Rocketed On A Deal With Pharma Giant Bayer.NEWS3: Doctor: We need to be vaccinating 'several times' the amount we're currently doing.NEWS4: English health chief says people will get COVID booster shots after guidance change.NEWS5: Italy's medicines agency approves Moderna's coronavirus vaccine.NEWS6: Moderna Has Big Plans For 2021.NEWS7: Business Needs to Hit Election Deniers in the Wallet.NEWS8: The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna and AstraZeneca.NEWS9: UK health minister says spacing COVID-19 vaccine doses will save more lives.NEWS10: Cruise Ship Stocks Struggling to Stay Afloat.NEWS11: COVID-19 vaccine deliveries under COVAX could start this month - WHO.NEWS12: Moderna (MRNA) COVID-19 Vaccine Gets Authorization in Europe.NEWS13: 3 Biotech Technological Developments to Watch Out For in 2021.NEWS14: The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration.NEWS15: Nearly 20,000 second doses of Pfizer vaccine given in England before rule change.NEWS16: Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy.NEWS17: Is AstraZeneca Stock a Buy?.NEWS18: WHO Europe urges safe flexibility on timing of COVID-19 vaccine doses.NEWS19: ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology.NEWS20: Debate Over Electoral Votes Resumes; Twitter Suspends Trump Account.NEWS21: Mexican with allergic reaction after Pfizer's COVID-19 vaccine still hospitalized.NEWS22: Electoral Count to Resume Tonight; Twitter Suspends Trump Account.NEWS23: AstraZeneca vaccine rollout in England extended to doctors' practices.
2021-01-08: NEWS1: BioNTech Jumps As Study Suggests Covid Vaccine Might Block New Strains.NEWS2: Biden to Release More Doses: Virus Update.NEWS3: Sarepta Tanks On Likely 2-Year Delay For Muscular Dystrophy Gene Therapy.NEWS4: COVID SCIENCE-Pfizer/BioNTech vaccine works against virus variants in lab; arthritis drugs improve COVID-19 survival.NEWS5: Biden plans to distribute COVID-19 vaccine doses immediately.NEWS6: Doctor: We're in a race against the case count 'to vaccinate as many people as possible'.NEWS7: American Airlines Has Room to Climb in 2021.NEWS8: 20 Biggest Questions in Science.NEWS9: Coronavirus update: Pfizer says vaccine may work against UK and South Africa strains; vaccinations to increase under Biden administration.NEWS10: Hospitals are ‘very stressed’ as COVID-19 cases surge across the U.S.: Doctor.NEWS11: What to Do With Sarepta’s Stock After Gene-Therapy Setback.NEWS12: FDA Commissioner Says States Should Expand Covid-19 Vaccine Eligibility.NEWS13: As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade.NEWS14: JPMorgan Chase (JPM) Testing 2020's All-Time High.NEWS15: Analyzing Pfizer's Unusual Options Activity.NEWS16: Moderna’s COVID-19 vaccine becomes third shot  authorized for use in U.K..NEWS17: P/E Ratio Insights for Pfizer.NEWS18: Germany secured 50 mln vaccine doses from CureVac, BioNTech on top of EU supplies - document.NEWS19: Pfizer (PFE) Begins Dosing in DMD Study With Gene Therapy.NEWS20: Sarepta (SRPT) Down on Unsatisfactory Data for DMD Candidate.NEWS21: Don't Expect Covid-19 Research to Deliver Certainty.NEWS22: Pharma Stock Roundup: ABBV's Positive Skyrizi Data, AZN, PFE, RHHBY's FDA Updates.NEWS23: Pfizer–BioNTech vaccine appears to protect against U.K. and South African COVID-19 strains in lab, study finds.NEWS24: Pfizer-BioNTech Vaccine Effective Against Mutation in New Covid-19 Variants, Study Finds.NEWS25: Dow 31,000, Boeing, Jobs Report, Pfizer, Micron - 5 Things You Must Know Friday.NEWS26: Europe's drug regulator says there is an extra dose in BioNTech/Pfizer's COVID-19 vaccine vials.NEWS27: Moderna's COVID-19 vaccine becomes third to be authorized by U.K. regulator.NEWS28: Pfizer Research Suggests Covid-19 Vaccine Will Protect Against New Variants.NEWS29: Boeing, Micron, Pfizer, Sarepta - Friday's Premarket Movers.NEWS30: Malaysia PM to announce new COVID-19 measures as deaths hit daily record.NEWS31: Pfizer and BioNTech say COVID-19 vaccine neutralizes mutation found in new U.K., South Africa variants.NEWS32: Why Pfizer Was a Surprising Loser in 2020 but Could Win Big Time in 2021.NEWS33: Would You Take Russia's Covid-19 Vaccine?.NEWS34: Coronavirus: a Sinovac Biotech vaccine is seen as effective in Brazil.NEWS35: Pfizer Study Shows Vaccine Efficacious Against COVID-19 Variant.NEWS36: Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study.NEWS37: Pfizer Stock: A Top Bet for 2021?.
2021-01-11: NEWS1: Pfizer (PFE) Gains As Market Dips: What You Should Know.NEWS2: BioNTech Surges On Its Plan To Make 2 Billion Covid Vaccine Doses In 2021.NEWS3: Sarepta Stock Gains as CEO Explains What Went Wrong With Gene-Therapy Trial.NEWS4: ‘Conditions are terrible:’ Los Angeles doctor on COVID-19 surge.NEWS5: Biden receives second dose of COVID-19 vaccine.NEWS6: Doctor on Arizona's alarming COVID-19 numbers: 'It’s really a dangerous time here'.NEWS7: BioNTech to offer vaccine to its own workers.NEWS8: BioNTech CEO Says a Version of Its Covid Vaccine With Less Stringent Storage Requirements Could Come This Year.NEWS9: In Senegal, lack of cold storage limits COVID vaccine options.NEWS10: Erdogan says Turkey to start COVID-19 vaccination Thursday or Friday.NEWS11: Futures Down as Investors Weigh Covid-19 Cases Against Vaccines.NEWS12: Racing Against Time: Covid-19 vs. Vaccines.NEWS13: EasyJet lands $1.87 billion state-backed loan as it looks to ease COVID cash crunch.NEWS14: BioMarin (BMRN) Reveals 1-Year Data on Hemophilia Gene Therapy.NEWS15: INSIGHT-Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way.NEWS16: 15 Biggest Vaccine Companies in the World.NEWS17: Your 3 Best Profit Opportunities in 2021.NEWS18: Why Israel Was the Perfect Test Case for Vaccines.NEWS19: CORRECTED-RPT-Scarce doses and empty vaccination centres: Germany's vaccine rollout headache.NEWS20: Malaysia buys additional 12.2 million doses of Pfizer-BioNTech COVID-19 vaccine.

Answer: Decrease